Mesothelioma is a rare and aggressive cancer that is difficult to diagnose because symptoms often mimic other diseases such as pulmonary fibrosis or lung cancer. Pathology reports and biopsies help distinguish this cancer from other illnesses, but often patients will have already developed more serious symptoms because the cancer has[…]
From the blog
Survival Rates Based Upon Subtypes of Mesothelioma
A recent study published in the British Journal of Cancer compared survival rates of mesothelioma patients that received their diagnosis through either cytological or by histological method for those with the epithelioid, biphasic, or sarcomatoid subtype of mesothelioma. The concern is that those with the biphasic subtype of mesothelioma are[…]
Phase I Clinical Trial Underway for CAR T-cell Therapy
A Phase I clinical trial for an immunotherapy treatment for malignant pleural mesothelioma and non-small cell lung cancer (NSCLC) is currently underway at the University of Pennsylvania in Philadelphia. Immunotherapy treatments support the body’s immune system response to diseases. It is often looked to as a positive alternative for treating[…]
Pembrolizumab Update: Aduro Biotech Collaborates with Merck
A biopharmaceutical company named Aduro Biotech recently announced its collaboration with Merck to further evaluate the findings for the Phase II trial of KEYTRUDA ® (pembrolizumab) and to combine their own immunotherapy treatment, CRS-207. Information regarding KEYTRUDA ® treatment began to circulate late last year when data presented at the[…]
Bevacizumab (Avastin): Part of a New Treatment Regimen for Mesothelioma Patients
The results of a 2016 Phase III trial of the monoclonal antibody bevacizumab (Avastin) have established another option for treatment for those suffering from malignant pleural mesothelioma. Angiogenesis, which is the formation of new blood vessels, plays a key role in mesothelioma because it allows the tumors and cancer to[…]
Surgical Techniques for Mesothelioma
While surgical techniques are not the most common effort when it comes to treating mesothelioma, the pleurectomy/decortication (P/D) is a technique that has been the most successful over the years. A recent study took a look at the different surgical techniques that can be used with P/D and noted the[…]
Success in Lung Cancer Treatment Gives Hope to Mesothelioma Patients
The latest success concerning a treatment for non- small cell lung cancer (NSCLC) has scientists and researchers hopeful that the same treatment can be applied to mesothelioma victims. The Phase III trial for Alecensa (alectinib), while currently not recruiting participants, is on-going and results thus far have shown to be[…]
Treatment Used In Multiple Sclerosis May Be Used In Mesothelioma
Although still in the preliminary stages, scientists and researchers are excited to announce recent research involving a treatment that is used for certain types of multiple sclerosis (MS) and its effects on combating mesothelioma. This therapeutic agent is called Immune System Modulator FTY720 (fingolimod) and is interestingly derived from a[…]
Nintedanib and Pembrolizumab – Hope for Mesothelioma Patients
The latest findings in cancer treatments for the often fatal mesothelioma have scientists and researchers hopeful that they are one step closer in finding a consistent, effective treatment for the asbestos-caused cancer. The LUME-Meso Phase II trial for patients with malignant pleural mesothelioma focused on the administration of the triple angiokinase[…]
National Asbestos Awareness Week: April 1 – April 7, 2017
On March 29, 2017 the U.S. Senate passed S. Res.98; a resolution designating the first week of April as “National Asbestos Awareness Week” in an attempt to warn and educate the public about asbestos exposure and its deadly health effects. Despite it being a known carcinogen and its ban in[…]
Skip to content